Akoya Biosciences Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Cash & Equivalents	-	535.68	493.55	503.6	527.39	422.84	Upgrade
Cash & Short-Term Investments	-	535.68	493.55	503.6	527.39	422.84	Upgrade
Cash Growth	-	8.54%	-2.00%	-4.51%	24.73%	6.11%	Upgrade
Accounts Receivable	-	463.09	491.99	464.22	436.22	440.87	Upgrade
Other Receivables	-	154.74	188.09	248.36	197.53	155.52	Upgrade
Receivables	-	617.83	680.07	712.58	633.75	596.4	Upgrade
Inventory	-	542.19	568.71	560.8	429.24	354.94	Upgrade
Other Current Assets	-	0	25.4	23.31	15.89	0.3	Upgrade
Total Current Assets	-	1,696	1,768	1,800	1,606	1,374	Upgrade
Property, Plant & Equipment	-	2,900	2,752	2,669	2,333	2,164	Upgrade
Long-Term Investments	-	160.45	84.86	80.8	92.77	77.87	Upgrade
Goodwill	-	1,159	1,185	1,205	1,157	1,119	Upgrade
Other Intangible Assets	-	158.63	174.17	183.07	173.65	170.81	Upgrade
Long-Term Deferred Tax Assets	-	103.53	112.23	126.21	68.01	68.97	Upgrade
Other Long-Term Assets	-	61.68	288.52	330.78	282.46	265.01	Upgrade
Total Assets	-	6,413	6,364	6,395	5,714	5,240	Upgrade
Accounts Payable	-	478.84	503.49	540.37	459.65	375.33	Upgrade
Accrued Expenses	-	181.98	209.51	176.37	148.15	138.57	Upgrade
Short-Term Debt	-	53.25	79.55	52.99	118.29	85.03	Upgrade
Current Portion of Long-Term Debt	-	156.18	256.41	189.18	252.83	80.35	Upgrade
Current Portion of Leases	-	46.23	45.15	47.54	55.5	47.38	Upgrade
Current Income Taxes Payable	-	25.94	18.52	14.81	27.56	24.56	Upgrade
Other Current Liabilities	-	138.85	147.18	120.58	136.94	145.5	Upgrade
Total Current Liabilities	-	1,081	1,260	1,142	1,199	896.71	Upgrade
Long-Term Debt	-	1,361	1,402	1,659	1,274	1,262	Upgrade
Long-Term Leases	-	166.62	155.72	161.05	159.88	157.56	Upgrade
Long-Term Deferred Tax Liabilities	-	297.27	273.35	325.19	219.8	214.2	Upgrade
Other Long-Term Liabilities	-	151.97	167.86	159.12	145.84	163.13	Upgrade
Total Liabilities	-	3,149	3,346	3,532	3,107	2,819	Upgrade
Common Stock	-	179.6	179.6	179.6	179.6	179.6	Upgrade
Additional Paid-In Capital	-	11.21	11.21	11.21	11.21	11.21	Upgrade
Treasury Stock	-	-34.76	-41.89	-47.1	-52.02	-53.59	Upgrade
Comprehensive Income & Other	-	2,805	2,584	2,445	2,221	2,049	Upgrade
Total Common Equity	-	2,961	2,733	2,588	2,359	2,186	Upgrade
Minority Interest	-	303.48	285.16	274.53	246.68	234.31	Upgrade
Shareholders' Equity	-	3,264	3,018	2,863	2,606	2,420	Upgrade
Total Liabilities & Equity	-	6,413	6,364	6,395	5,714	5,240	Upgrade
Total Debt	-	1,783	1,939	2,109	1,861	1,632	Upgrade
Net Cash (Debt)	-	-1,247	-1,445	-1,606	-1,334	-1,209	Upgrade
Net Cash Per Share	-	-27.86	-32.32	-35.80	-29.72	-26.90	Upgrade
Filing Date Shares Outstanding	44.74	44.44	44.38	44.26	44.18	44.13	Upgrade
Total Common Shares Outstanding	44.74	44.44	44.38	44.26	44.18	44.13	Upgrade
Working Capital	-	614.45	507.92	658.44	407.36	477.77	Upgrade
Book Value Per Share	-	66.63	61.57	58.48	53.41	49.54	Upgrade
Tangible Book Value	-	1,643	1,374	1,200	1,029	896.44	Upgrade
Tangible Book Value Per Share	-	36.98	30.95	27.12	23.28	20.31	Upgrade
Land	-	1,694	1,619	1,514	1,319	1,310	Upgrade
Machinery	-	4,375	4,047	3,975	3,250	3,085	Upgrade
Construction In Progress	-	410.18	361.34	284.66	417.33	257.74	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.